Last updated on June 2017

Patients needed for high triglyceride / high cholesterol study "Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Arm, 12-week Study to Evaluate the Safety and Efficacy of Saroglitazar Magnesium 1, 2 and 4 mg in Patients With Fasting Triglyceride ≥ 500 mg/dL and ≤ 1500 mg/dL"


Brief description of study

Patients needed for high triglyceride / high cholesterol study "Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Arm, 12-week Study to Evaluate the Safety and Efficacy of Saroglitazar Magnesium 1, 2 and 4 mg in Patients With Fasting Triglyceride ≥ 500 mg/dL and ≤ 1500 mg/dL"

Detailed Study Description

A multicenter, prospective, randomized, double-blind, placebo-controlled, parallel arm, 12-week study designed to evaluate the safety and efficacy of Saroglitazar Magnesium 1, 2 and 4 mg in patients with fasting triglyceride ≥ 500 mg/dL and ≤ 1500 mg/dL.

Clinical Study Identifier: TX150193

Find a site near you

Start Over

Cedar Crosse Research Center

800 S Wells, Suite M15 Chicago, IL USA
  Connect »